Provider roles in the recruitment of underrepresented populations to cancer clinical trials

Cancer

Volumn 109, Issue 3, 2007, Pages 465-476

  Howerton, Mollie W ^a,b   Gibbons, M Chris ^a,c,d,e   Baffi, Charles R ^f   Gary, Tiffany L ^a,e,g   Lai, Gabriel Y ^e   Bolen, Shari ^a   Tilburt, Jon ^a   Tanpitukpongse, Teerath Peter ^h   Wilson, Renee F ^a   Powe, Neil R ^e,g   Bass, Eric B ^a,c,e   Ford, Jean G ^a,b,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Center for Community Health (CCH)   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Accrual; Cancer; Clinical trials; Minorities; Providers; Recruitment; Systematic review; Underrepresented populations; Underserved

Indexed keywords

BIBLIOGRAPHIC DATABASE; CANCER; CASE CONTROL STUDY; CLINICAL PROTOCOL; COST; DESCRIPTIVE RESEARCH; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; MINORITY GROUP; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUALITATIVE RESEARCH; REFUSAL TO PARTICIPATE; REVIEW; SYSTEMATIC REVIEW; TRUST;

CLINICAL TRIALS; HEALTH PERSONNEL; HUMANS; MINORITY GROUPS; NEOPLASMS; PATIENT SELECTION; ROLE;

EID: 33846671682     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22436     Document Type: Review

References (33)

1. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol. 2002;20:2109-2117.
2. Swanson GM, Bailar JC. Selection and description of cancer clinical trials participants-science or happenstance? Cancer. 2002;95:950-959.
3. National Institutes of Health. Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research. Available at URL: www4.od. nih.gov/orwh/GoldReport_2000-01.pdf Accessed October 1, 2004; 2003.
4. National Institutes of Health. Guidelines on the inclusion of women and minorities as subjects in clinical research (updated). Bethesda, MD: NIH; 2000.
5. Clinical Trials Working Group of the National Cancer Advisory Board. Restructuring the National Cancer Clinical Trials Enterprise, June 2005; Bethesda, MD.
6. Ford JG, Howerton MW, Bolen S, et al. Evidence report on knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Baltimore, MD: Johns Hopkins University Evidence-based Practice Center; June 2005:05-E019-2.
7. US Department of Health and Human Services. Making cancer health disparities history: report of the Trans-HHS Cancer Health Disparities Progress. Executive Summary Review Group; 2004:vi-vii.
8. Agency for Healthcare Research and Quality. National health disparities report. In: US Department of Health and Human Services, eds. Rockville, MD; 2004.
9. Grade Working Group. Grading quality of evidence and strength of recommendations. Br Med J. 2004;328:1490.
10. Benson AB 3rd, Pregler JP Bean JA, Rademaker AW, Eshler B, Anderson K. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol. 1991;9:2067-2075.
11. Richardson JL, Myrtle R, Solis JM, et al. Participation of community medical oncologists in clinical research trials. Prog Clin Biol Res. 1986;216:269-280.
12. Spaight SJ, Nash S, Finison LJ, et al. Medical oncologists' participation in cancer clinical trials. Prog Clin Biol Res. 1984;156:49-61.
13. Fallowfield L, Ratcliffe D, Souhami R. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer. 1997;33:2221-2229.
14. McCaskill-Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol. 1999;17:1029-1039.
15. Ellington L, Wahab S, Sahami Martin S, Field R, Mooney KH. Factors that influence Spanish- and English-speaking participants' decision to enroll in cancer randomized clinical trials. Psychooncology. 2006;15:273-284.
16. Kemeny MM, Peterson BL, Kornblith AB, et al. Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol. 2003;21:2268-2275.
17. Kimmick GG, Peterson BL, Kornblith AB, et al. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol. 2005;23:2201-2207.
18. Kornblith AB, Kemeny M, Peterson BL, et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer. 2002;95:989-996.
19. Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19:1728-1733.
20. Leitch AM, Beitsch PD, McCall LM, et al. Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. Am J Surg. 2005;190:539-542.
21. Martel CL, Li Y, Beckett L, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004;10:294-300.
22. Melisko ME, Hassin F, Metzroth L, et al. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. Clin Breast Cancer. 2005;6:45-54.
23. Nguyen TT, Somkin CP Ma Y. Participation of Asian-American women in cancer chemoprevention research: physician perspectives. Cancer. 2005;104:3006-3014.
24. Paskett ED, Cooper MR, Stark N, et al. Clinical trial enrollment of rural patients with cancer. Cancer Pract. 2002;10:28-35.
25. Pinto HA, McCaskill-Stevens W, Wolfe P, et al. Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) initiative. Ann Epidemiol. 2000;10(8 suppl):S78-84.
26. Sherwood PR, Given BA, Scholnik A, Given CW. To refer or not to refer: factors that affect primary care provider referral of patients with cancer to clinical treatment trials. J Cancer Educ. 2004;19:58-65.
27. Simon MS, Du W, Flaherty L, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol. 2004;22:2046-2052.
28. Grunfeld E, Zitzelsberger L, Coristine M, et al. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer. 2002;95:1577-1583.
29. Wendler D, Kington R, Madans J, et al. Vol 3. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3:0201-0210.
30. National Cancer Institute. Community Clinical Oncology Program. Bethesda, MD: NCI; 2006.
31. Somkin CP, Altschuler A, Ackerson L, et al. Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care. 2005;11:413-421.
32. Twelves CJ, Thomson CS, Young J, et al. Entry into clinical trials in breast cancer: the importance of specialist teams. Scottish Breast Cancer Focus Group and Scottish Cancer Therapy Network. Bur J Cancer. 1998;34:1004-1007.
33. Jatoi A, Hillman S, Stella P, et al. North Central Cancer Treatment Group. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol. 2005;23:9113-9119.